Conventional measures underestimate glycaemia in cystic fibrosis patients
- 21 June 2004
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 21 (7) , 691-696
Abstract
Diabetes mellitus is an increasingly important complication of cystic fibrosis (CF). The association with increased morbidity of cystic fibrosis-related diabetes (CFRD) has emphasized the need for accurate monitoring of glycaemia in all CF patients. The diagnosis has relied on conventional thresholds in an oral glucose tolerance test (OGTT) derived from epidemiological studies in non-CF subjects. However, it has not been established if these values are equivalent in CF and non-CF populations. We compared glycaemia in 21 non-diabetic CF subjects with 21-age and BMI-matched non-CF controls using HbA(1c), OGTT and a subcutaneous continuous glucose monitoring system (CGMS) that measures interstitial glucose levels. All conventional measures of glycaemia were similar in the two groups: HbA(1c) mean CF vs. controls (5.5 vs. 5.3%P = 0.4), fasting glucose (4.8 vs. 4.7 mmol/l P = 0.7) and 2-h glucose (5.8 vs. 5.7 mmol/l P = 0.8). However, these conventional measures did not accurately reflect glycaemia 30-, 60- and 90-min. Glucose values and area under the curve in OGTT were all higher in CF subjects than controls (P = 0.01-0.0001). Mean CGMS value [5.9 (0.8) vs. 5.1 (0.5) mmol/l, P = 0.004], and the proportion of subjects with peak CGMS values > 11.1 mmol/l (33 vs. 5%P = 0.00001) were also higher in CF subjects than controls. These results remained significantly different when only subjects with normal glucose tolerance in the two groups were studied. We have shown that overall glycaemia, as shown by both the response during an OGTT and CGMS, is higher in CF subjects who have similar HbA(1c), fasting and 2-h glucose values. These results question whether it is appropriate to use the diagnostic thresholds and OGTT time points derived from the non-CF population for a diagnosis of diabetes in patients with cystic fibrosis.Keywords
This publication has 32 references indexed in Scilit:
- Cystic fibrosis‐related diabetes: the role of peripheral insulin resistance and β‐cell dysfunctionDiabetic Medicine, 2002
- Cystic fibrosis‐related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy*Acta Paediatrica, 2001
- Insulin improves clinical status of patients with cystic‐fibrosis‐related diabetes mellitusActa Paediatrica, 2001
- Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosisEuropean Journal of Pediatrics, 1995
- Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosisEuropean Journal of Pediatrics, 1992
- Pancreatic endocrine function in cystic fibrosisThe Journal of Pediatrics, 1991
- Oral glucose tolerance testing in cystic fibrosis: Correlations with clinical parameters and glycosylated haemoglobin determinationsEuropean Journal of Pediatrics, 1991
- Diabetes mellitus associated with cystic fibrosisThe Journal of Pediatrics, 1988
- Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance.Journal of Clinical Investigation, 1979
- Pancreatic alpha and beta cell functions in cystic fibrosisThe Journal of Pediatrics, 1977